Skip to main content
Have a personal or library account? Click to login
Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III Cover

Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III

Radiology and Oncology
Volume 45 (2011): Issue 3 (September 2011)
By: ,  ,  ,  ,  ,   and    
Open Access
|Aug 2011
References

References

  1. Pesta M, Topolcan O, Holubec L, Rupert K, Cerna M, Holubec L, et al. Clinicopathological assesment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.2007;1863-8.
    Search in Google Scholar
  2. Li M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metaloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth and angiogenesis.2006;20-7.
    Open DOISearch in Google Scholar
  3. Giaginis C, Nikiteas N, Margeli A, Tzanakis N, Rallis G, Kouraklis G, et al. Serum tissue inhibitor of metalloproteinase 1 and 2 (TIMP-1 and TIMP-2) levels in colorectal cancer patients: association with clinicopathological variables and patients survival.2009;245-52.
    Open DOISearch in Google Scholar
  4. Alo-Aho R, Kahari VM. Colagenases in cancer.2005;273-86.
    Open DOISearch in Google Scholar
  5. Sørensen NM, Sørensen IV, Wűrtz SØ, Schrohl AS, Dowell B, Davis G, et al. Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment.2008;774-86.
    Open DOISearch in Google Scholar
  6. Frederiksen CB, Lomholt AF, Lottenburger T, Davis GJ, Dowell BL, Blankenstein MA, et al. Assesment of the biological variation of plasma tissue inhibitor of metalloproteinase-1.2008;42-7.
    Open DOISearch in Google Scholar
  7. Horvat M, Stabuc B. Microsatellite instability in colorectal cancer.2011;75-81.
    Open DOISearch in Google Scholar
  8. Yaolin Zhou Y, Boardman LA, Miller RC. Genetic testing for young-onset colorectal cancer: case report and evidence-based clinical guidelines.2010;57-61.
    Search in Google Scholar
  9. Wass ET, Hendriks T, Lomme RM, Woblles T. Plasma levels of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 correlate with disease stage and survival in colorectal cancer patients.2005;700-10.
    Open DOISearch in Google Scholar
  10. Kahlert C, Bandapalli OR, Schirmacher P, Weitz J, Brand K. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer.2008;1459-66.
    Search in Google Scholar
  11. Holten-Andersen MN, Murphy G, Nielsen HJ, Pedersen AN, Christensen IJ, Høyer-Hansen G, et al. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.1999;495-503.
    Open DOISearch in Google Scholar
  12. Hammer JH, Basse L, Svendsen MN, Werther K, Brüner N, Christensen IJ, et al. Impact of elective resection on plasma TIMP-1 in patients with colon cancer.2006;168-72.
    Open DOISearch in Google Scholar
  13. Holten-Andersen MN, Christensen IJ, Nielsen HJ, Stephens RW, Jensen V, Nielsen OH, et al. Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer.2002;156-64.
    Search in Google Scholar
  14. Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Stetler-Stevenson W, et al. High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.2000;4292-9.
    Search in Google Scholar
  15. Sofic A, Beslic S, Kocijancic I, Sehovic N. CT colonography in detection of colorectal carcinoma.2010;19-23.
    Open DOISearch in Google Scholar
  16. Oblak I, Petric P, Anderluh F, Velenik V, Hudej R, Fras AP. Anal cancer chemoirradiation with curative intent - a single institution experience.2009;150-5.
    Open DOISearch in Google Scholar
  17. Ishida H, Murata N, Hayashi Y, Tada M, Hashimoto D. Serum levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) in colorectal cancer patients.2003;885-92.
    Open DOISearch in Google Scholar
  18. Tayebjee MH, Lip GYH, Blann AD, MacFadyen RJ. Effects of age, gender, ethnicity, diurnal variations and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.2005;205-10.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-011-0027-2 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 209 - 212
Published on: Aug 26, 2011
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
TIMP-1,
rectal cancer,
healthy blood donors
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2011 Irena Oblak, Franc Anderluh, Vaneja Velenik, Barbara Mozina, Janja Ocvirk, Eva Ciric, Natasa Podvrsnik, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 45 (2011): Issue 3 (September 2011)
Previous article
Next article